MENU
ORKA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Oruka Therapeutics (ORKA) Ownership - Who owns Oruka Therapeutics?

Oruka Therapeutics Inc a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications... Show more

Profile

Industry
N/A
Address
855 Oak Grove Avenue
Phone
+1 650 606-7910
Employees
68
Web
https://www.orukatx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
6.29B
P/E Ratio
N/A
Total Cash
873.56M
Projected Growth
N/A
Total Debt
2.55M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
13.19
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
ORKA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
855 Oak Grove Avenue
Phone
+1 650 606-7910
Employees
68
Web
https://www.orukatx.com
Who owns Oruka Therapeutics? ORKA symbol Ownership - Tickeron.com